| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2300477 | QL2107注射液 | Pembrolizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-07-13 | QILU Pharmaceutical Co Ltd | view |